Loading...
XSWXMEDX
Market cap381mUSD
Dec 23, Last price  
8.40CHF
1D
0.72%
1Q
-12.86%
IPO
-80.99%
Name

medmix AG

Chart & Performance

D1W1MN
XSWX:MEDX chart
P/E
1,142.08
P/S
0.70
EPS
0.01
Div Yield, %
4.38%
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
1.40%
Revenues
487m
+1.99%
454,000,000420,700,000351,300,000457,300,000477,100,000486,600,000
Net income
300k
-97.41%
52,200,00025,200,0009,600,00044,000,00011,600,000300,000
CFO
56m
+17.86%
94,200,00089,100,00050,600,00087,300,00047,600,00056,100,000
Dividend
Apr 26, 20240.5 CHF/sh

Profile

Medmix AG designs, develops, manufactures, and delivers high-precision devices and services for the mixing, application, and injection of liquids in a range of viscosities for the healthcare, consumer, and industrial end markets worldwide. It operates through five segments: Dental, Drug Delivery, Surgery, Industry, and Beauty. The Dental segment offers mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, restorations, anesthetics, and aesthetics. The Drug Delivery segment offers drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases. The Surgery segment provides mixing and delivery devices which are used to inject bone cement, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. The Industry segment produces and markets dispensers, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics, infrastructure, and general industrial sectors. The Beauty segment offers micro brushes, mascara, lip gloss and concealers. The company offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Zug, Switzerland.
URL
https://www.medmix.ch
IPO date
Sep 30, 2021
Employees
2,245
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
486,600
1.99%
477,100
4.33%
457,300
30.17%
Cost of revenue
473,600
428,300
394,700
Unusual Expense (Income)
NOPBT
13,000
48,800
62,600
NOPBT Margin
2.67%
10.23%
13.69%
Operating Taxes
2,200
600
7,300
Tax Rate
16.92%
1.23%
11.66%
NOPAT
10,800
48,200
55,300
Net income
300
-97.41%
11,600
-73.64%
44,000
358.33%
Dividends
(15,000)
(15,000)
(41,300)
Dividend yield
1.92%
2.07%
2.22%
Proceeds from repurchase of equity
(3,100)
295,500
288,200
BB yield
0.40%
-40.85%
-15.52%
Debt
Debt current
42,200
164,100
24,200
Long-term debt
378,400
380,900
362,400
Deferred revenue
4,600
6,700
Other long-term liabilities
27,400
(100)
100
Net debt
276,600
225,000
176,700
Cash flow
Cash from operating activities
56,100
47,600
87,300
CAPEX
(46,400)
(38,600)
(31,900)
Cash from investing activities
(80,600)
(57,000)
(3,300)
Cash from financing activities
(153,800)
116,100
111,600
FCF
(12,500)
23,500
23,100
Balance
Cash
130,600
316,800
210,000
Long term investments
13,400
3,200
(100)
Excess cash
119,670
296,145
187,035
Stockholders' equity
588,800
517,300
540,400
Invested Capital
731,830
680,355
664,565
ROIC
1.53%
7.17%
8.43%
ROCE
1.49%
4.92%
7.19%
EV
Common stock shares outstanding
41,204
41,100
41,112
Price
19.00
7.95%
17.60
-61.03%
45.16
 
Market cap
782,870
8.23%
723,360
-61.04%
1,856,635
 
EV
1,118,070
948,360
2,033,335
EBITDA
68,400
99,900
114,300
EV/EBITDA
16.35
9.49
17.79
Interest
10,100
6,500
8,100
Interest/NOPBT
77.69%
13.32%
12.94%